Advanced Life Sciences (ADLS) Stock Price, News & Analysis

Company Overview

Advanced Life Sciences Inc. is a biopharmaceutical company and its lead candidate, Restanza, is a novel once-a-day oral antibiotic in late-stage development for the treatment of life-threatening infections including community-acquired bacterial pneumonia and biodefense pathogens including anthrax, plague and tularemia. The Company has developed a promising pipeline of clinical and preclinical product candidates from both in-licensing efforts and the discovery programs in the areas of infectious disease, oncology, and respiratory disease. It develops ALS-357, a natural product in preclinical studies has demonstrated specific anti-tumor activity against malignant melanoma. It has a unique mechanism of action that disrupts mitochondrial membrane function and is associated with the intrinsic, mitochondria-mediated pathway of apoptosis. The Company develops ALS-886, a novel treatment intended to reduce and prevent the tissue damage associated with diseases such as Adult Respiratory Distress Syndrome (ARDS).

Key Stats

• Today's Range: $0.01 to $0.01
• 50-Day Range: $0.01 to $0.01
• 52-Week Range: $0.0001 to $0.01
• Volume: 1,000 shs
• Average Volume: 4,868 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ADLS Stock Analysis - Frequently Asked Questions

How have ADLS shares performed this year?

Advanced Life Sciences' stock was trading at $0.01 on January 1st, 2025. Since then, ADLS shares have increased by 0.0% and is now trading at $0.01.
View the best growth stocks for 2025 here.

How do I buy shares of Advanced Life Sciences?

Shares of ADLS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Advanced Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Advanced Life Sciences investors own include Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF (PDBC), Toyota Motor (TM), Micron Technology (MU), Kroger (KR), Kinder Morgan (KMI), Kimberly-Clark (KMB) and Freeport-McMoRan (FCX).

Company Calendar

• Today: 7/03/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biological Products, Except Diagnostic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:ADLS
• CIK: N/A
• Web: www.advancedlifesciences.com
• Phone: 630-739-6744
• Fax: 630-739-6754
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A